Hello Jenni Nordborg!

Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.

Carl Borrebaeck – professor and serial entrepreneur with a taste for speed

Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borreb...

Marie Gårdmark: Potential step change – EU regulators get to play with data

A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approva...

Startup-bolaget vill bli nästa Olink

Inte ens ett år gamla har Rarity Bioscience fått anslag från Swelife och Medtech4health. Nu hoppas vd:n Linus Bosaeus att deras teknik för detektion av mutation...

Neanderthal genes and Nobel Prize in a popular lecture at Bioscience

An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...

Study: An objective diagnosis of constant tinnitus may be possible

A new method that measures brain activity during sound stimulation can make it possible to objectively diagnose and identify people who suffer from constant tin...

“An entire industry is about to be wiped out”

According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.

Göran Stiernstedt: “We are the world’s worst at continuity”

Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Miljontals munskydd stoppades i tullen

Tullverket stoppade i fjol nästan sju miljoner munskydd och andra sjukvårdsprodukter som bedömdes som osäkra – en gigantisk ökning jämfört med året innan.

Norrländsk life science går för högtryck

Pharma Outsourcing igång på Stockholm Waterfront

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

"Det var inget lätt beslut att fatta"

Två av Recipharms svenska anläggningar läggs ner och 225 anställda berörs av beslutet. Här berättar bolagets vd.

Pengaregn över hälsoprojekt

22 projekt inom läkemedel, medtech och e-hälsa delar på 20,5 miljoner i Vinnova-utlysning.

Column: Repurposing as a golden ticket to approval

"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...

Drug development creates new challenges for regulators

Miljonregn till kampen mot infektioner

Nio infektionsforskare får dela på 225 miljoner kronor.

Tappar i värde

Värdet på Karolinska Developments portfölj har minskat med 225 miljoner kronor men bolaget fortsätter med sin nya strategi.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

New diagnostic test soon ready for the market

De fick pengar för djurfri forskning

Forska utan djurförsök tillkännager 2018 års anslag.

Astrazeneca licencierar in astmapreparat

Satsar på ett nytt projekt för behandling av virusorsakad förvärrande av astma.

Hon får Scheelepriset

Professor Emmanuelle Charpentier tilldelas 2019 års Scheelepris. Hon har spelat en avgörande roll i upptäckten av gensaxen Crispr-Cas9.